{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:37:59Z","timestamp":1772462279278,"version":"3.50.1"},"reference-count":72,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"3","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2026,3,2]]},"DOI":"10.1167\/tvst.15.3.3","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:30:35Z","timestamp":1772458235000},"page":"3","source":"Crossref","is-referenced-by-count":0,"title":["Beyond the Globe: Molecular Diagnostics of Optic Nerve, Orbital, and Adnexal Neoplasms"],"prefix":"10.1167","volume":"15","author":[{"given":"Amanda","family":"Dankberg","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanqiao","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto J.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27","reference":[{"key":"bib3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00401-015-1410-7","article-title":"Pilocytic astrocytoma: pathology, molecular mechanisms and markers","volume":"129","author":"Collins","year":"2015","journal-title":"Acta Neuropathol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/modpathol.2013.79","article-title":"Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system","volume":"26","author":"Reis","year":"2013","journal-title":"Mod Pathol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/jmg.2010.081760","article-title":"A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations","volume":"48","author":"Sharif","year":"2011","journal-title":"J Med Genet"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00401-015-1467-3","article-title":"A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation","volume":"130","author":"Ho","year":"2015","journal-title":"Acta Neuropathol"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/NEN.0b013e3182656ef8","article-title":"BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper","volume":"71","author":"Rodriguez","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"bib11","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/WNO.0000000000000550","article-title":"Optic pathway gliomas in neurofibromatosis type 1: an update: surveillance, treatment indications, and biomarkers of vision","volume":"37","author":"de Blank","year":"2017","journal-title":"J Neuroophthalmol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S1470-2045(09)70033-6","article-title":"Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1","volume":"10","author":"Brems","year":"2009","journal-title":"Lancet Oncol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1101\/gr.142604.112","article-title":"Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma","volume":"23","author":"Gutmann","year":"2013","journal-title":"Genome Res"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/nan.12145","article-title":"A comparative analysis of MAPK pathway hallmark alterations in pilocytic astrocytomas: age-related and mutually exclusive","volume":"41","author":"Brokinkel","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/neuonc\/noab047","article-title":"A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study","volume":"23","author":"Fangusaro","year":"2021","journal-title":"Neuro Oncol"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1200\/JCO.21.00784","article-title":"Integrated molecular-morphologic meningioma classification: a multi-center retrospective analysis, retrospectively and prospectively validated","volume":"39","author":"Maas","year":"2021","journal-title":"J Clin Oncol"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/bpa.12150","article-title":"Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma","volume":"25","author":"Ho","year":"2015","journal-title":"Brain Pathol"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/neuonc\/noae170","article-title":"cIMPACT-NOW update 8: clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas","volume":"27","author":"Sahm","year":"2025","journal-title":"Neuro Oncol"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1097\/00000478-199506000-00017","article-title":"Giant cell angiofibroma. A distinctive orbital tumor in adults","volume":"19","author":"Dei Tos","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ng.2522","article-title":"Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors","volume":"45","author":"Chmielecki","year":"2013","journal-title":"Nat Genet"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng.2509","article-title":"Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing","volume":"45","author":"Robinson","year":"2013","journal-title":"Nat Genet"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/08820538.2019.1620802","article-title":"A review of the role of cytogenetics in the diagnosis of orbital rhabdomyosarcoma","volume":"34","author":"Cortes Barrantes","year":"2019","journal-title":"Semin Ophthalmol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.survophthal.2025.03.009","article-title":"Primary ocular, adnexal, and orbital rhabdomyosarcoma: a review","volume":"70","author":"Agarwal","year":"2025","journal-title":"Surv Ophthalmol"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0161-6420(01)00840-5","article-title":"Clinical spectrum of primary ophthalmic rhabdomyosarcoma","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmology"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.humpath.2023.12.004","article-title":"Rhabdomyosarcoma: updates on classification and the necessity of molecular testing beyond immunohistochemistry","volume":"147","author":"Dehner","year":"2024","journal-title":"Hum Pathol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ejca.2022.05.036","article-title":"Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: a consensus view from European Paediatric Soft Tissue Sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe","volume":"172","author":"Hettmer","year":"2022","journal-title":"Eur J Cancer"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/gcc.23010","article-title":"Clinicopathologic and survival correlates of embryonal rhabdomyosarcoma driven by RAS\/RAF mutations","volume":"61","author":"Agaram","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1158\/2159-8290.CD-13-0639","article-title":"Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors","volume":"4","author":"Shern","year":"2014","journal-title":"Cancer Discov"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1097\/IOP.0000000000002252","article-title":"Spindle cell\/sclerosing rhabdomyosarcoma of the orbit","volume":"39","author":"Proia","year":"2023","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3390\/cancers17091441","article-title":"TFCP2 fusion-positive rhabdomyosarcomas: a report of 10 cases and a review of the literature","volume":"17","author":"Ginn","year":"2025","journal-title":"Cancers (Basel)"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"100271","DOI":"10.1016\/j.modpat.2023.100271","article-title":"Fusion-driven spindle cell rhabdomyosarcomas of bone and soft tissue: a clinicopathologic and molecular genetic study of 25 cases","volume":"36","author":"Dehner","year":"2023","journal-title":"Mod Pathol"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/IOP.0000000000002484","article-title":"Hybrid schwannoma-perineurioma of the orbit","volume":"40","author":"Zhou","year":"2024","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"E103","DOI":"10.1002\/humu.20793","article-title":"Germline and somatic NF1 gene mutations in plexiform neurofibromas","volume":"29","author":"Upadhyaya","year":"2008","journal-title":"Hum Mutat"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1038\/onc.2016.464","article-title":"The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas","volume":"36","author":"Pemov","year":"2017","journal-title":"Oncogene"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"e13007","DOI":"10.1111\/bpa.13007","article-title":"RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas","volume":"32","author":"Imada","year":"2022","journal-title":"Brain Pathol"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2017.05.010","article-title":"Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1\u2014a consensus overview","volume":"67","author":"Miettinen","year":"2017","journal-title":"Hum Pathol"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/neuonc\/noad053","article-title":"Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities","volume":"25","author":"Kresbach","year":"2023","journal-title":"Neuro Oncol"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/neuonc\/noae235","article-title":"Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of neurofibromatosis type 1 (NF1)","volume":"27","author":"Lucas","year":"2025","journal-title":"Neuro Oncol"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/ng.3688","article-title":"The genomic landscape of schwannoma","volume":"48","author":"Agnihotri","year":"2016","journal-title":"Nat Genet"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"100427","DOI":"10.1016\/j.modpat.2024.100427","article-title":"Systematic characterization of the clinical and pathological features of schwannomas harboring SH3PXD2A::HTRA1 fusion","volume":"37","author":"Lee","year":"2024","journal-title":"Mod Pathol"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/humu.20679","article-title":"Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas","volume":"29","author":"Sestini","year":"2008","journal-title":"Hum Mutat"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/ng.2855","article-title":"Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas","volume":"46","author":"Piotrowski","year":"2014","journal-title":"Nat Genet"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1212\/WNL.0000000000001129","article-title":"Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis","volume":"84","author":"Smith","year":"2015","journal-title":"Neurology"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/neuonc\/noad121","article-title":"Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs","volume":"25","author":"Williams","year":"2023","journal-title":"Neuro Oncol"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/jnen\/nlad080","article-title":"Orbital SOX10-mutant schwannoma with plexiform growth: expanding the histopathological spectrum of a new molecular group","volume":"82","author":"Wali","year":"2023","journal-title":"J Neuropathol Exp Neurol"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1046\/j.1365-2559.1998.00419.x","article-title":"Nerve sheath tumours with hybrid features of neurofibroma and schwannoma: a conceptual challenge","volume":"32","author":"Feany","year":"1998","journal-title":"Histopathology"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/PAS.0b013e31824d3155","article-title":"Hybrid neurofibroma\/schwann-oma is overrepresented among schwannomatosis and neurofibromatosis patients","volume":"36","author":"Harder","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00428-004-1102-5","article-title":"A benign neoplasm with histopathological features of both schwannoma and retiform perineurioma (benign schwannoma-perineurioma): a report of six cases of a distinctive soft tissue tumor with a predilection for the fingers","volume":"445","author":"Michal","year":"2004","journal-title":"Virchows Arch"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1177\/1066896906293417","article-title":"Benign schwannoma with perineurioma-like areas: a clinicopathologic study of 11 cases","volume":"14","author":"Kazakov","year":"2006","journal-title":"Int J Surg Pathol"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.anndiagpath.2005.11.004","article-title":"Benign hybrid perineurioma-schwannoma in the colon. A case report","volume":"10","author":"Emanuel","year":"2006","journal-title":"Ann Diagn Pathol"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.anndiagpath.2008.02.012","article-title":"Hybrid neurofibroma-perineurioma: an additional example of an extradigital tumor","volume":"12","author":"Shelekhova","year":"2008","journal-title":"Ann Diagn Pathol"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/PAS.0000000000001858","article-title":"Clinicopathologic and molecular study of hybrid nerve sheath tumors reveals their common association with fusions involving VGLL3","volume":"46","author":"Nihous","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41379-021-00783-0","article-title":"Hybrid schwannoma-perineurioma frequently harbors VGLL3 rearrangement","volume":"34","author":"Dickson","year":"2021","journal-title":"Mod Pathol"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1172\/JCI130787","article-title":"Targetable ERBB2 mutations identified in neurofibroma\/schwannoma hybrid nerve sheath tumors","volume":"130","author":"Ronellenfitsch","year":"2020","journal-title":"J Clin Invest"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"102183","DOI":"10.1016\/j.labinv.2024.102183","article-title":"Genomic landscape of superficial malignant peripheral nerve sheath tumor","volume":"105","author":"McAfee","year":"2025","journal-title":"Lab Invest"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/1947601910373795","article-title":"The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-kappaB\/Snail\/RKIP\/PTEN circuit","volume":"1","author":"Lin","year":"2010","journal-title":"Genes Cancer"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1186\/s12885-018-5190-z","article-title":"Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis","volume":"18","author":"Rose","year":"2018","journal-title":"BMC Cancer"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ophtha.2018.12.047","article-title":"Genetic profiling of primary orbital melanoma: an analysis of 6 cases with clinicopathologic correlation","volume":"126","author":"Mudhar","year":"2019","journal-title":"Ophthalmology"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1097\/IOP.0000000000002081","article-title":"GNA11 mutation in an intracranial melanocytoma with orbital involvement and nevus of Ota","volume":"38","author":"Zhou","year":"2022","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.prp.2016.07.009","article-title":"Orbital meningeal melanocytoma: Histological, immunohistochemical and molecular characterization of a case and review of the literature","volume":"212","author":"Palicelli","year":"2016","journal-title":"Pathol Res Pract"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","article-title":"Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites","volume":"18","author":"Streubel","year":"2004","journal-title":"Leukemia"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Honma","year":"2009","journal-title":"Blood"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/modpathol.2016.79","article-title":"Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies","volume":"29","author":"Cani","year":"2016","journal-title":"Mod Pathol"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/bjophthalmol-2021-319580","article-title":"Prevalence and prognostic value of MYD88 and CD79B mutations in ocular adnexal large B-cell lymphoma: a reclassification of ocular adnexal large B-cell lymphoma","volume":"107","author":"Kirkegaard","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.rdc.2013.02.011","article-title":"Erdheim-Chester disease","volume":"39","author":"Haroche","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1200\/JCO.2014.57.1950","article-title":"Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease","volume":"33","author":"Haroche","year":"2015","journal-title":"J Clin Oncol"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ajo.2018.01.037","article-title":"Ophthalmic findings of Rosai-Dorfman disease","volume":"188","author":"Choi","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/modpathol.2017.55","article-title":"Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease","volume":"30","author":"Garces","year":"2017","journal-title":"Mod Pathol"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.2147\/JIR.S365098","article-title":"Clinicopathological and gene mutation analysis of 27 cases with extranodal Rosai-Dorfman disease","volume":"15","author":"Tang","year":"2022","journal-title":"J Inflamm Res"},{"key":"bib72","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and targetable kinase alterations drive histiocytic neoplasms","volume":"6","author":"Diamond","year":"2016","journal-title":"Cancer Discov"},{"key":"bib1","volume-title":"Eye and Orbit Tumours","author":"International Agency for Research on Cancer","year":"2023"},{"key":"bib2","volume-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis","year":"2016"},{"key":"bib5","volume-title":"Tumors of the Eye and Ocular Adnexa","author":"Folberg","year":"2020"},{"key":"bib20","volume-title":"WHO Classification of Soft Tissue and Bone Tumours","author":"International Agency for Research on Cancer","year":"2020"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?doi=10.1167\/tvst.15.3.3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:30:36Z","timestamp":1772458236000},"score":1,"resource":{"primary":{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?doi=10.1167\/tvst.15.3.3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.15.3.3","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,2]]}}}